Review

Type 1 Diabetes, Diabetic Nephropathy, and Pregnancy: A Systematic Review and Meta-Study

Giorgina B. Piccoli¹, Roberta Clari¹, Sara Ghiotto¹, Natascia Castelluccia², Nicoletta Colombi², Giuseppe Mauro², Elisabetta Tavassoli³, Carmela Melluzza³, Gianfranca Cabiddu⁴, Giuseppe Gernone⁴, Elena Mongilardi¹, Martina Ferraresi¹, Alessandro Rolfo³, Tullia Todros³

Manuscript submitted April 6, 2013; resubmitted April 25, 2013; accepted April 26, 2013.

Keywords: type 1 diabetes, nephropathy, pregnancy, preeclampsia, chronic kidney disease, preterm delivery

Abstract

BACKGROUND: In the last decade, significant improvements have been achieved in maternal-fetal and diabetic care which make pregnancy possible in an increasing number of type 1 diabetic women with end-organ damage. Optimal counseling is important to make the advancements available to the relevant patients and to ensure the safety of mother and child. A systematic review will help to provide a survey of the available methods and to promote optimal counseling. OBJECTIVES: To review the literature on diabetic nephropathy and pregnancy in type 1 diabetes. METHODS: Medline, Embase, and the Cochrane Library were scanned in November 2012 (MESH, Emtree, and free terms on pregnancy and diabetic nephropathy). Studies were selected that report on pregnancy outcomes in type 1 diabetic patients with diabetic nephropathy in 1980-2012 (i.e. since the detection of microalbuminuria). Case reports with less than 5 cases and reports on kidney grafts were excluded. Paper selection and data extraction were performed in duplicate and matched for consistency. As the relevant reports were highly heterogeneous, we decided to perform a narrative review, with discussions oriented towards the period of publication. RESULTS: Of the 1058 references considered, 34 fulfilled the selection criteria, and one was added from reference lists. The number of cases considered in the reports, which generally involved single-center studies, ranged from 5 to 311. The following issues were significant: (i) the evidence is scattered over many reports of differing format and involving small series (only 2 included over 100 patients), (ii) definitions are non-homogeneous, (iii) risks for pregnancy-related adverse events are increased (preterm delivery, caesarean section, perinatal death, and stillbirth) and do not substantially change over time, except for stillbirth (from over 10% to about 5%), (iv) the increase in risks with nephropathy progression needs confirmation in large homogeneous series, (v) the newly reported increase in malformations in diabetic nephropathy underlines the need for further studies. CONCLUSIONS: The heterogeneous evidence from studies on diabetic nephropathy in pregnancy emphasizes the need for further perspective studies on this issue.

Fulltext: HTML , PDF (745KB)

This article has been cited by other articles:

	Diagnosis and Management of IUGR in Pregnancy Complicated by Type 1 Diabetes Mellitus Gutaj P, Wender-Ozegowska E Curr Diab Rep 2016. 16(5):39
	Managing pregnancy in chronic kidney disease: improving outcomes for mother and baby Fitzpatrick A, Mohammadi F, Jesudason S Int J Womens Health 2016. 8:273-285
	A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy Cabiddu G, Castellino S, Gernone G, Santoro D, Moroni G, Giannattasio M, Gregorini G, Giacchino F, Attini R, Loi V, Limardo M, Gammaro L, Todros T, Piccoli GB J Nephrol 2016. 29(3):277-303
	A Systematic Review and Meta-Analysis of Kidney and Pregnancy Outcomes in IgA Nephropathy Liu Y, Ma X, Zheng J, Liu X, Yan T Am J Nephrol 2016. 44(3):187-193
	Type 1 and Type 2 Diabetes Preconception and in Pregnancy: Health Impacts, Influence of Obesity and Lifestyle, and Principles of Management Abell SK, Nankervis A, Khan KS, Teede HJ Semin Reprod Med 2016. 34(2):110-120
	Diabetic Nephropathy in Women With Preexisting Diabetes: From Pregnancy Planning to Breastfeeding Ringholm L, Damm JA, Vestgaard M, Damm P, Mathiesen ER Curr Diab Rep 2016. 16(2):12
	Piper betel leaves induces wound healing activity via proliferation of fibroblasts and reducing 11beta hydroxysteriod dehydrogenase-1 expression in diabetic rat Ghazali NA, Elmy A, Yuen LC, Sani NZ, Das S, Suhaimi F, Yusof R, Yusoff NH, Thent ZC J Ayurveda Integrat Med 2016. 7(4):198-208
	Risk of Adverse Pregnancy Outcomes in Women with CKD Piccoli GB, Cabiddu G, Attini R, Vigotti FN, Maxia S, Lepori N, Tuveri M, Massidda M, Marchi C, Mura S, Coscia A, Biolcati M, Gaglioti P, Nichelatti M, Pibiri L, Chessa G, Pani A, Todros T J Am Soc Nephrol 2015. 26(8):2011-2022
	Vascular complications in the diabetic pregnancy Leguizamon G, Trigubo D, Pereira JI, Vera MF, Fernandez JA Curr Diab Rep 2015. 15(4):22
	Pregnancy in CKD: Questions and answers in a changing panorama Piccoli GB, Cabiddu G, Attini R, Vigotti F, Fassio F, Rolfo A, Giuffrida D, Pani A, Gaglioti P, Todros T Best Pract Res Clin Obstet Gynaecol 2015. In press
	A review of the use of piper betel in oxidative stress disorders Lee CY, Nurul Zaidah AS, Nur Amalina G, Muhammad Azree E, Das S, Zar CT Clin Ter 2014. 165(5):269-277
	Clinical Significance of the Expression of Serum Connective Tissue Growth Factor and Tumor Necrosis Factor in Patients with Diabetic Nephropathy Liu HY, Wang R, Shi JL J Clin Res 2014. In press
	Selected renal diseases in pregnancy Zakiyanov O, Vachek J, Tesar V Kardiol Rev 2014. 16(1):67-73